IDIBELL researchers define a new mechanism of aging in a bone marrow stem cell in women

by Hospital Universitari de Bellvitge

Researchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.

Read more

Aptadel, the new IDIBELL’s spinoff

by Hospital Universitari de Bellvitge

Aptadel Therapeutics is a preclinical company co-founded by IDIBELL focused on developing a new platform for targeted therapy against cancer. This platform consists of nanoparticles loaded with therap...

Read more

Descubren la actividad inmunomoduladora de un fármaco que mejoraría la eficacia de la inmunoterapia contra el cáncer de mama

by CNIO - Centro Nacional de Investigaciones Oncológicas

El equipo de Eva González-Suarez, del CNIO y del IDIBELL, y el equipo de Christos Sotiriou, de Instituto Jules Bordet, demuestran que un fármaco usado ya para el tratamiento de la osteoporosis promu...

Read more

The combination of two immunomodulatory drugs could be beneficial for more severe Covid-19 patients

by Hospital Universitari de Bellvitge

A total of 44 researchers from the Bellvitge Biomedical Research Institute (IDIBEL​L) and Bellvitge University Hospital (HU​B) sign an article in the International Journal of Infect​ious Disease...

Read more

Bellvitge estudiará la aplicación de la inteligencia artificial en el tratamiento del COVID-19 en las UCI

by Hospital Universitari de Bellvitge

El Servicio de Medicina Intensiva del Hospital Universitario de Bellvitge participa, a través del Instituto de Investigación Biomédica de Bellvitge (IDIBELL), en el proyecto europeo ENVISION, que d...

Read more

Presented a program capable of automatically detecting neurodegeneration biomarkers through magnetic resonance imaging

by Hospital Universitari de Bellvitge

This tool is able to identify single-person neurodegeneration before the symptom’s appearance, which could significate a more effective and personalized medicine.

Read more

Descubren una nueva enfermedad genética del sistema nervioso y cardíaco

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

El estudio, liderado por investigadores del IDIBELL, el Hospital Sant Joan de Déu y el CIBERER, se publica en la prestigiosa revista ‘Acta Neuropathologica’

Read more

ALKBH3 biomarker helps predict Hodgkin lymphoma aggressiveness

by Hospital Universitari de Bellvitge

Dysregulation of RNA and protein levels, compared to normal tissues, is a consistent molecular feature of all cancers. Behind the causes of these changes, chemical modifications have recently been ide...

Read more

The use of water pipes and passive exposure to their smoke are as harmful as conventional tobacco

by Hospital Universitari de Bellvitge

Smoking in water pipes and passive exposure to the smoke they produce, increase the risk of lung cancer and other cardiovascular diseases. It is for this reason that its use should be regulated and co...

Read more

ADmit Therapeutics recibe 3,3 millones de euros de la Comisión Europea para llevar su prueba de diagnóstico precoz del Alzheimer al mercado

by ADmit Therapeutics

La spin-of del IDIBELL, creada en 2017 y con sede en L'Hospitalet de Llobregat, es una de las 36 empresas seleccionadas de entre las 1.406 solicitudes recibidas en la convocatoria EIC Accelerator del ...

Read more

Mediante un modelo de ratón identifican una nueva combinación de fármacos para tratar rabdomiosarcoma, un tumor altamente agresivo en niños

by ICO - Institut Català d'Oncologia

El grupo de quimiorresistencia del Programa PROCURE del ICO-IDIBELL, liderado por Alberto Villanueva, ha trasladado su experiencia en la generación de modelos ortotópicos de ratones en pacientes adu...

Read more

A mouse model was used to determine the personalized treatment for a cancer patient

by Hospital Universitari de Bellvitge

A team from IDIBELL and ICO, using a mouse orthotopic model, conducted a real-time personalized oncology study to test the best therapeutic option to treat a type of relapse sarcoma.

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

by Labo'Life

Photos Stream